Opinion statement
Since 1993, with the advent of felbamate, physicians have been blessed with the addition of eight new antiepileptic medications for the treatment of epilepsy. Increasing evidence is accumulating that these drugs are effective as monotherapy agents. The use of monotherapy minimizes side effects, and newer drugs have fewer interactions than many of the older antiepileptic medications with comparable efficacy. Using the newer antiepileptic agents in monotherapy, even as an initial therapy would appear to be an appropriate clinical decision.
Similar content being viewed by others
References and Recommended Reading
Willner AN: Epilepsy in Clinical Practice. New York: Demos; 1990.
Hauser WA, Hesdorffer DC: Epilepsy: Frequency, Causes and Consequences. New York: Demos; 1990.
Cascino GD, Jack CR: Neuroimaging in Epilepsy: Principles and Practice. Boston: Butterworth-Heinemann; 1996.
Gates JR: Epidemiology and classification of nonepileptic events. In Non-Epileptic Seizures. Edited by Gates JR, Rowan AJ. Boston: Butterworth-Heinemann; 2000:3–14. An important article.
Shorvon SD: Antiepileptic drugs. In Handbook of Epilepsy Treatment. Malden: Blackwell Science; 2000:158.
Patrias J, Gates JR: Advances in medical treatment of epilepsy. Health One Med J 1992, 1:27–31.
Gates, Penovich PE, Ritter FJ: The newest antiepileptic drugs. Med J Health Span 1993, 2:21–26.
Gates JR: Side effect profiles and behavioral consequences of antiepileptic medications. Epilepsy Behav 2003, 1:153–159.
Antiepileptic Drugs, edn 4. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; 1995.
Sachedo R, Beydoun A, Schachter S, et al.: Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 2001, 57:864–871.
Beydoun A, Sachdeo RC, Rosenfeld WE, et al.: Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 2000, 54:2245–2251.
Schachter SC, Vazquez B, Fisher RS, et al.: Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 2000, 52:732–737.
Bergey GK, Morris HH, Rosenfeld W, et al.: Gabapentin monotherapy: I. An 8-day, double-blind, dose controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89. Neurology 1997, 49:739–745.
Beydoun A, Sackellares JC, Shu V: Safety and efficacy of divalproex sodium monotherapy in partial epilepsy: A double-blind, concentration-response design clinical trial. Depakote Monotherapy for Partial Seizures Study Group. Neurology 1997, 48:182–188.
Beydoun A, Fischer J, Labar DR, et al.: Gabapentin monotherapy: II. A 26-week, double-blind, dosecontrolled, multicenter of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The IS Gabapentin Study Group 82/83. Neurology 1997, 49:746–752.
Sachdeo RC, Reif RA, Lim P, Pledger G: Topiramate monotherapy for partial onset seizures. Epilepsia 1997, 38:294–300.
Devinsky O, Sanchez-Villasenor F, Vazquez B, et al.: Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res 1995, 20:241–246.
Schachter SC: Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia 1995, 36:S2-S6.
Theodore WH, Albert P, Stertz B, et al.: Felbamate monotherapy: implications for antiepileptic drug development. Epilepsia 1995, 36:1105–1110.
Gilliam F: An active-control trial of lamotrigine monotherapy for partial seizures. Neurology 1998, 51:1018–1025.
Devinsky O, Faught RE, Wilder BJ, et al.: Efficacy of felbamate monotherapy in patients undergoing presurgical evaluation of partial seizures. Epilepsy Res 1995, 20:241–246.
Faught E, Sachdeo RC, Remler MP, et al.: Felbamate monotherapy for partial onset seizures. Epilepsia 1993, 38:294–300.
Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S: Felbamate monotherapy: controlled trial in patients with partial onset seizures. Ann Neurol 1992, 32:386–392.
Dam M, Ekberg R, Loyning Y, et al.: A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989, 3:70–76.
Guerreiro MM, Vigonius U, Pohlmann H, et al.: A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 1997, 27:205–213.
Christie W: A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 1997, 26:451–460.
Chadwick DW, Anhut H, Greiner MJ, et al.: A doubleblind trial of gabapentin monotherapy for newly diagnosed partial seizures. Neurology 1998, 51:1282–1288.
Beydoun A: Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 1999, 40:S13-S16.
Gilliam FG, Veloso F, Bomhof MA, et al.: A dosecomparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003, 60:196–202.
Schachter SC: Tiagabine monotherapy in the treatment of partial epilepsy. Epilepsia 1995, 36:S2-S6.
Gates JR: Summary: zonisamide. Presented at the Fifth Eilat Conference on New Antiepileptic Drugs. Eilat, Israel; June 2000.
Ben-Menachem E: Preliminary efficacy of levetiracetam in monotherapy. Epileptic Disord 2003, 5:S51-S55.
Privitera MD, Brodie MJ, Mattson RH, et al.: Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003, 107:165–175.
Lee S, Sziklas V, Andermann F, et al.: The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003, 44:339–347.
Gates JR, Dunn ME: Presurgical assessment and surgical treatment for epilepsy. Acta Neurol Belg 1999, 4:281–294.
Cramer JA, Mattson RH: Compliance with antiepileptic drug therapy. In Antiepileptic Drugs, edn 4. Edited by Levy RH, Mattson RH, Meldrum BS. New York: Raven Press; 1995.
Gates JR: Sports participation for people with epilepsy. Phys Sportsmed 1991, 19:98–104.
French JA, Schachter SC: A workshop on antiepileptic drug monotherapy indications. Epilepsia 2002, 43:10. An important article.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gates, J.R. Using new antiepileptic drugs as monotherapy. Curr Treat Options Neurol 6, 223–230 (2004). https://doi.org/10.1007/s11940-004-0014-7
Issue Date:
DOI: https://doi.org/10.1007/s11940-004-0014-7